drugset / Trial / NCT00968422

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

NCT00968422

Phase 1 Completed 28 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ABT-384 in elderly subjects.

Timeline

Start
2009-08
Primary completion
2010-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-384 Small molecule

Indications

No indication recorded.